生物标志物在动脉粥样硬化性心血管疾病风险分层中的作用的现状和未来展望

IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

European Cardiology Review Pub Date : 2023-01-01 DOI:10.15420/ecr.2022.57

Bruna Gigante

{"title":"生物标志物在动脉粥样硬化性心血管疾病风险分层中的作用的现状和未来展望","authors":"Bruna Gigante","doi":"10.15420/ecr.2022.57","DOIUrl":null,"url":null,"abstract":"© The Author(s) 2023. Published by Radcliffe Group Ltd. www.ECRjournal.com Atherosclerotic cardiovascular diseases (ASCVD) remain the leading cause of death in Europe, with more than 4 million deaths in 2017.1 Ischaemic heart disease and stroke account for 82% of disability-adjusted life years (DALYs) in European Society of Cardiology member countries, even though ASCVD incidence has declined during the past 27 years.1","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/d3/ecr-18-e13.PMC10316363.pdf","citationCount":"0","resultStr":"{\"title\":\"Present and Future Perspectives on the Role of Biomarkers in Atherosclerotic Cardiovascular Disease Risk Stratification.\",\"authors\":\"Bruna Gigante\",\"doi\":\"10.15420/ecr.2022.57\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"© The Author(s) 2023. Published by Radcliffe Group Ltd. www.ECRjournal.com Atherosclerotic cardiovascular diseases (ASCVD) remain the leading cause of death in Europe, with more than 4 million deaths in 2017.1 Ischaemic heart disease and stroke account for 82% of disability-adjusted life years (DALYs) in European Society of Cardiology member countries, even though ASCVD incidence has declined during the past 27 years.1\",\"PeriodicalId\":45957,\"journal\":{\"name\":\"European Cardiology Review\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/d3/ecr-18-e13.PMC10316363.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Cardiology Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15420/ecr.2022.57\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Cardiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/ecr.2022.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Present and Future Perspectives on the Role of Biomarkers in Atherosclerotic Cardiovascular Disease Risk Stratification.

© The Author(s) 2023. Published by Radcliffe Group Ltd. www.ECRjournal.com Atherosclerotic cardiovascular diseases (ASCVD) remain the leading cause of death in Europe, with more than 4 million deaths in 2017.1 Ischaemic heart disease and stroke account for 82% of disability-adjusted life years (DALYs) in European Society of Cardiology member countries, even though ASCVD incidence has declined during the past 27 years.1

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Cardiology Review CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

5.40

自引率

0.00%

发文量

审稿时长

12 weeks